Impact of the COVID-19 pandemic on fecal immunochemical testing, colonoscopy services, and colorectal neoplasia detection in a large United States community-based population
The COVID-19 pandemic has impacted clinical services globally, including colorectal cancer (CRC) screening and diagnostic testing. We investigated the pandemic ’s impact on fecal immunochemical test (FIT) screening, colonoscopy utilization, and colorectal neoplasia detection across 21 medical centers in a large integrated healthcare organization.
Source: Gastroenterology - Category: Gastroenterology Authors: Jeffrey K. Lee, Angela Y. Lam, Christopher D. Jensen, Amy R. Marks, Jessica Badalov, Evan Layefsky, Kevin Kao, Ngoc J. Ho, Joanne E. Schottinger, Nirupa R. Ghai, Cheryl M. Carlson, Ethan A. Halm, Beverly Green, Dan Li, Douglas A. Corley, Theodore R. Levin Source Type: research
More News: Cancer | Cancer & Oncology | Colonoscopy | Colorectal Cancer | COVID-19 | Gastroenterology | Pandemics | USA Health